retatrutide type 2 diabetes phase 2 results 2024 ada 💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with diabetes, a new 3 trial shows. is part of an emerging generation ADA 2026: Retatrutide Revolution

Frias JP, Davies MJ, Rosenstock J, Perez Manghi FC, Fernandez Lando L, Bergman BK, et al

Triple-Receptor Research Profile

As of April 2026, two trials have read out and seven more are expected to report through the year, with NDA filing targeted for Q4 2026

Not all psychiatrists prescribe them currently, but its a fair question to ask

Personalized Weight Loss Strategies : Each plan is customized to fit your health goals and lifestyle, ensuring results that meet your unique needs

Similar to the observation in myocytes, the top predicted ligands for upregulated genes included TGF1 and WNT5b, while predicted ligands for downregulated genes included TGF1 and slc6a8 ( note: different genes in the TGF 1 pathway were enriched amongst down-versus up-regulated genes following semaglutidethis is unsurprising, as cytokines like TGF 1 induce gene suppression as well as activation, and the effects of semaglutide impact both vectors of transcriptional change )